Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 4Recruiting 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2INDIV 2

Study Type

Observational 2Interventional 2

Sponsor

Conditions

Myasthenia Gravis 4

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Pyridostigmine Bromide × Clear all
NCT05919407 2023-06-26

IMPACT-MG

Leiden University Medical Center

Phase 3 Unknown
24 enrolled

Myasthenia Gravis

NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

NCT04768465 2021-02-24

Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis

Da, Yuwei, M.D.

Unknown
160 enrolled

Myasthenia Gravis

NCT03510546 2018-04-27

Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis

University of Aarhus

Phase 4 Unknown
44 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡